{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Eli Lilly", "item": "https://www.patentleaderboard.com/company/lilly"}, {"@type": "ListItem", "position": 3, "name": "Deyi Zhang", "item": "https://www.patentleaderboard.com/inventor/fl:de_ln:zhang-8"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DZ

Deyi Zhang — 13 Patents

Eli Lilly: 9 patents #393 of 2,858Top 15%
CTCb Therapeutics: 1 patents #8 of 16Top 50%
C(Crown Bioscience, Inc. (Taicang): 1 patents #5 of 31Top 20%
HTHuazhong University Of Science And Technology: 1 patents #389 of 1,292Top 35%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Deyi Zhang has been granted 13 US patents while listed as an inventor at Eli Lilly. The first was granted in 2007 and the most recent in September 2021. Deyi Zhang ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Deyi Zhang in 浮桥镇, IN, CN.

Patents per Year

Patents granted per year, 2007 to 2021Bar chart with a peak of 2 patents in 2007.peak 22007: 2 patents20072008: 1 patents2009: 1 patents20092010: 1 patents2011: 2 patents20112013: 1 patents2014: 1 patents20142016: 1 patents2017: 1 patents20172018: 1 patents2021: 1 patents2021

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11127535 Ferroelectric enhanced solar cell and preparation method thereof Hongwei HAN, Anyi MEI, Shuang LIU, Xiaolei Li 2021-09-21
10023593 ALK kinase inhibitor, and preparation method and uses thereof Jiaqiang Dong, Boyu Zhong, Hongbin Yuan, Chuan Shih, Shaosong Chu +1 more 2018-07-17
9840477 Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents 2017-12-12
9359338 Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents Ruihao Zhang, Boyu Zhong, Chuan Shih 2016-06-07
8748459 Pyridinoylpiperidines as 5-HT1F agonists Michael Philip Cohen, Daniel Timothy Kohlman, Sidney Liang, Frantz Victor, Yao-Chang Xu +2 more 2014-06-10 $245,503,000
8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist John Gordon Allen, Karin Briner, Christopher Stanley Galka, Maria Angeles Martinez-Grau, Matthew Robert Reinhard +9 more 2013-11-12 $216,055,000
8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists John Gordon Allen, Karin Briner, Michael Philip Cohen, Christopher Stanley Galka, Sarah Lynne Hellman +8 more 2011-09-20 $59,131,000
7981882 6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists Karin Briner, Anne Marie Camp, Alan Cornell, Michael Philip Mazanetz, Roger Ryan Rothhaar +2 more 2011-07-19 $50,826,000
7754742 Imidazole carboxamides Albert Khilevich, Bin Liu, Daniel Ray Mayhugh, Jeffrey Michael Schkeryantz 2010-07-13 $168,310,000
7608629 (Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HT1F agonists Maria Jesus Blanco-Pillado, Dana Rae Benesh, Sandra Ann Filla, Kevin John Hudziak, Brian Michael Mathes +3 more 2009-10-27 $81,965,000
7423050 Pyridinoylpiperidines as 5-HT1F agonists Michael Philip Cohen, Daniel Timothy Kohlman, Sidney Liang, Vincent Mancuso, Yao-Chang Xu +3 more 2008-09-09 $138,526,000
7312236 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT1F agonists Daniel Timothy Kohlman, Frantz Victor, Yao-Chang Xu, Bai-Ping Ying 2007-12-25
7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists Maria Jesus Blanco-Pillado, Michael Philip Cohen, Sandra Ann Filla, Kevin John Hudziak, Daniel Timothy Kohlman +6 more 2007-11-06 $65,050,000